Try it
Pediatrics · Immunisation: RSV prevention
Sample itemWhich approach protects young infants against severe RSV bronchiolitis in the first months of life?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Nirsevimab monoclonal antibody to the infant, or maternal RSV vaccine in late pregnancy
Nirsevimab is a long-acting monoclonal antibody given to infants, and maternal RSV prefusion F vaccine during pregnancy gives passive antibody protection. Both reduce RSV hospitalisation in young infants.
Option by option
A. BCG vaccine
BCG does not protect against RSV.
B. Antibiotic prophylaxis
Antibiotics do not prevent viral infection.
C. Oral zinc
Zinc has no role in RSV prevention.
D. Nirsevimab monoclonal antibody to the infant, or maternal RSV vaccine in late pregnancy (correct)
Correct. These are the two approved strategies.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pediatrics questions
- Congenital heart diseaseWhich is the most common cyanotic congenital heart disease presenting beyond the neonata…
- NutritionWhich feature most clearly distinguishes kwashiorkor from marasmus?
- NeonatologyA newborn becomes visibly jaundiced in the first 24 hours of life. What is the most like…
- Diarrhoeal diseasesA child with diarrhoea has 'some dehydration'. What is the recommended initial management?